K.J. Harrison & Partners’s iShares Biotechnology ETF IBB Stock Holding History

K.J. Harrison & Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,635	Closed	-$266K	–	393
2021 Q3	$266K	Sell	1,635 -1,000	-38%	-$168K	0.04%	244
2021 Q2	$432	Buy	+2,635	New	+$406K	0.05%	217
2019 Q2	–	Sell	-6,455	Closed	-$722K	–	159
2019 Q1	$722K	Sell	6,455 -700	-10%	-$76.8K	0.25%	96
2018 Q4	$690K	Hold	7,155	–	–	0.42%	62
2018 Q3	$872K	Hold	7,155	–	–	0.22%	120
2018 Q2	$786K	Hold	7,155	–	–	0.23%	116
2018 Q1	$764K	Hold	7,155	–	–	0.25%	107
2017 Q4	$764K	Sell	7,155 -34,035	-83%	-$3.64M	0.26%	105
2017 Q3	$4.58M	Buy	+41,190	New	+$4.4M	1.58%	15
2016 Q4	–	Sell	-3,450	Closed	-$333K	–	216
2016 Q3	$333K	Sell	3,450 -300	-8%	-$28.5K	0.16%	153
2016 Q2	$322K	Buy	+3,750	New	+$336K	0.17%	139

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

K.J. Harrison & Partners's IBB Position: Q4 2021 in Review

K.J. Harrison & Partners sold out of iShares Biotechnology ETF (IBB) in Q4 2021, closing a stake of 1,635 shares — an estimated $266K sold.

K.J. Harrison & Partners first reported a position in IBB in Q2 2016 and held it in 11 quarters. The position peaked at $4.58M in Q3 2017. 963 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

K.J. Harrison & Partners reported no remaining iShares Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
K.J. Harrison & Partners sold 1,635 iShares Biotechnology ETF shares in Q4 2021, an estimated $266K.
K.J. Harrison & Partners first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 11 quarters.
K.J. Harrison & Partners's iShares Biotechnology ETF position peaked at $4.58M in Q3 2017.
963 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on K.J. Harrison & Partners's 13F filing for Q4 2021, filed 26 Jan 2022.